Total Payments
$1.9M
2024 Payments
$190,920
Companies
43
Transactions
2,109
Medicare Patients
116
Medicare Billing
$11,553
Payment Breakdown by Category
Other$1.4M (74.2%)
Travel$263,439 (13.7%)
Consulting$184,573 (9.6%)
Food & Beverage$48,999 (2.5%)
Education$365.46 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.4M | 453 | 73.6% |
| Travel and Lodging | $263,439 | 685 | 13.7% |
| Consulting Fee | $184,573 | 51 | 9.6% |
| Food and Beverage | $48,999 | 909 | 2.5% |
| Honoraria | $10,029 | 2 | 0.5% |
| Education | $365.46 | 9 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $805,678 | 900 | $0 (2024) |
| EMD Serono, Inc. | $388,385 | 460 | $0 (2024) |
| GENZYME CORPORATION | $344,489 | 353 | $0 (2024) |
| TG Therapeutics, Inc. | $152,734 | 101 | $0 (2024) |
| Genentech USA, Inc. | $118,676 | 86 | $0 (2024) |
| Acorda Therapeutics, Inc | $40,132 | 40 | $0 (2021) |
| Horizon Therapeutics plc | $14,651 | 29 | $0 (2023) |
| Celgene Corporation | $10,105 | 15 | $0 (2023) |
| Amgen Inc. | $9,877 | 17 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $9,444 | 8 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $190,920 | 159 | EMD Serono, Inc. ($93,451) |
| 2023 | $315,815 | 263 | EMD Serono, Inc. ($155,195) |
| 2022 | $187,736 | 216 | Biogen, Inc. ($115,447) |
| 2021 | $178,848 | 210 | Biogen, Inc. ($133,633) |
| 2020 | $125,460 | 142 | Biogen, Inc. ($83,930) |
| 2019 | $275,890 | 378 | Biogen, Inc. ($118,254) |
| 2018 | $301,761 | 341 | Biogen, Inc. ($141,501) |
| 2017 | $347,813 | 400 | GENZYME CORPORATION ($146,781) |
All Payment Transactions
2,109 individual payment records from CMS Open Payments — Page 1 of 85
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $62.11 | General |
| 12/23/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,555.00 | General |
| Category: Neurology | ||||||
| 12/13/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $15.22 | General |
| 12/12/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $140.57 | General |
| Category: Immunology | ||||||
| 12/04/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $58.76 | General |
| 12/03/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Travel and Lodging | Cash or cash equivalent | $374.08 | General |
| Category: Neurology | ||||||
| 12/02/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Travel and Lodging | Cash or cash equivalent | $693.61 | General |
| Category: Neurology | ||||||
| 12/02/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Travel and Lodging | Cash or cash equivalent | $604.02 | General |
| Category: Neurology | ||||||
| 12/02/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Travel and Lodging | Cash or cash equivalent | $511.88 | General |
| Category: Neurology | ||||||
| 12/02/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Travel and Lodging | Cash or cash equivalent | $284.04 | General |
| Category: Neurology | ||||||
| 11/27/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $62.72 | General |
| 11/21/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $52.96 | General |
| 11/19/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,555.00 | General |
| Category: Neurology | ||||||
| 11/19/2024 | Amgen Inc. | UPLIZNA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,225.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/19/2024 | Amgen Inc. | UPLIZNA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/14/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,712.50 | General |
| Category: Immunology | ||||||
| 11/13/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $99.29 | General |
| 11/12/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Travel and Lodging | In-kind items and services | $797.95 | General |
| Category: Immunology | ||||||
| 11/06/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $37.65 | General |
| 11/02/2024 | Amgen Inc. | UPLIZNA (Biological) | Travel and Lodging | In-kind items and services | $963.96 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/02/2024 | Amgen Inc. | UPLIZNA (Biological) | Travel and Lodging | In-kind items and services | $303.97 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/02/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $49.99 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/02/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $49.99 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/02/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/02/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Inflammation/Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 19 | 32 | $7,696 | $2,586 |
| 2021 | 2 | 38 | 47 | $7,945 | $3,508 |
| 2020 | 3 | 59 | 77 | $14,841 | $5,459 |
Total Patients
116
Total Services
156
Medicare Billing
$11,553
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 32 | $7,696 | $2,586 | 33.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 24 | 31 | $5,791 | $2,782 | 48.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 16 | $2,154 | $725.30 | 33.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 26 | 34 | $6,388 | $2,401 | 37.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 18 | 26 | $6,272 | $2,201 | 35.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 15 | 17 | $2,181 | $857.50 | 39.3% |
About Dr. Kenneth Mankowski, DO
Dr. Kenneth Mankowski, DO is a Neurology healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942261243.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Mankowski, DO has received a total of $1.9M in payments from pharmaceutical and medical device companies, with $190,920 received in 2024. These payments were reported across 2,109 transactions from 43 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.4M).
As a Medicare-enrolled provider, Mankowski has provided services to 116 Medicare beneficiaries, totaling 156 services with total Medicare billing of $11,553. Data is available for 3 years (2020–2022), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Columbus, OH
- Active Since 03/28/2006
- Last Updated 05/09/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1942261243
Products in Payments
- TYSABRI (Biological) $382,765
- AUBAGIO (Drug) $325,024
- TECFIDERA (Drug) $190,574
- Mavenclad (Drug) $162,300
- BRIUMVI (Drug) $145,280
- VUMERITY (Drug) $127,670
- MAVENCLAD (Drug) $123,820
- OCREVUS (Biological) $91,941
- AMPYRA (Drug) $40,081
- Mavenclad (Biological) $35,746
- Non-Covered Product (Drug) $26,885
- Tysabri (Biological) $25,235
- UPLIZNA (Drug) $14,651
- Rebif (Biological) $14,181
- UPLIZNA (Biological) $9,819
- COPAXONE (Drug) $9,444
- LEMTRADA (Drug) $8,580
- PLEGRIDY (Biological) $7,858
- DISEASE STATE (Drug) $7,163
- Ozanimod (Drug) $6,939
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Columbus
Dr. Aaron Boster, Md, MD
Neurology — Payments: $1.9M
Neurology $1.9M
Danielle Becker, Md, MD
Neurology — Payments: $1.3M
Neurology $1.3M
Dr. Jacqueline Nicholas, M.d, M.D
Neurology — Payments: $967,203
Neurology $967,203
Dr. Jonathan Liss, M.d, M.D
Neurology — Payments: $468,143
Neurology $468,143
Jerry Mendell, Md, MD
Neurology — Payments: $371,804
Neurology $371,804
Dr. Andrew Smith, M.d, M.D
Neurology — Payments: $277,150
Neurology $277,150